Puma Biotechnology Reports Q3 2026: Revenue Misses Estimates at $55.1M, GAAP EPS Exceeds at $0.11
Raising Full-Year 2026 Net Income Guidance on Steady NERLYNX Demand Related Stocks: PBYI ,
Raising Full-Year 2026 Net Income Guidance on Steady NERLYNX Demand Related Stocks: PBYI ,